Merck COVID Pill Approval
Current information on efficacy and side effects of Molnupiravir
The big news as I write this is the FDA approval of Merck’s CV19 treatment pill Molnupiravir. This post is intended to provide a few sources for you to do your own reading. As with my previous post, it is not intended to provide medical advice.
Any negative side effects or lack of efficacy relative to Merck’s original claims may get obscured going forward as has been the case with the vaccines. It would not be at all surprising if we are talking about this pill as part of a mandate in several months. So be sure to share this information with friends and family so they can make informed decisions. If the new pill becomes the next “proven safe and effective” treatment for CV19, they may not see this information elsewhere unless they make a real effort.
As stated previously, when having these discussions it is important to keep in mind what we are talking about when weighing the risks of a treatment versus the risks of CV19. Yes, people die from CV19. Yes, some of these treatments will have an effect against CV19. But the risk of serious illness or death from CV19 for a healthy person is EXTREMELY low. See my previous post here for further discussion on that (linked below as well).
As for Molnupiravir, what are the risks and benefits? Merck initially claimed it reduced the risk of hospitalization or death from CV19 by approximately 50% compared to a placebo. Sounds pretty good. So an FDA advisory panel approved the drug for emergency use by a vote of 13-10 on November 30, 2021. Apparently on the same day, Merck provided new information indicating the drug is 30% effective, not the 50% previously stated:
FDA advisory panel narrowly endorses Merck’s oral Covid treatment pill, despite reduced efficacy and safety questions
Also probably worth noting this passage from the above article. Keep this in mind in the event the recommendations are ever evolving on this as they are with vaccines…and we are again asked to blindly ignore any unfavorable information:
“The FDA and Merck both recommended against using the drug in kids and pregnant women. Molnupiravir was found to be lethal to embryos in pregnant rats, also causing birth defects and reducing fetal body weight. It also caused other defects that interfered with bone growth in young pups, along with other abnormalities, the data shows.”
The following series of articles touches on these issues as well as the potential for this pill to create “supercharged” variants of CV19:
Supercharging New Viral Variants: The Dangers Of Molnupiravir (Part 1)
Harming Those Who Receive It: The Dangers Of Molnupiravir (Part 2)
And a couple other headlines on the risks:
New Merck study results raise questions about its COVID pill
Molnupiravir: long-term safety questions linger as approvals approach
Again, not that Merck, with FDA approval, would ever fudge the numbers and harm anyone, right??
Of course, there are other drugs Merck has produced that were actually safe and effective. This is all just to say do your own research and don’t be brainwashed like so many have been with other aspects of CV19. Will this pill become the next “vaccine” with the same arguments like “ but, but it’s proven safe and effective” followed by proposed mandates? We do not know yet.
Armed with the above information at hand, everyone will need to make their own choices when presented with this pill. As with the vaccines, you should do your own risk/benefit analysis, consult with your doctor when sick, and decide if the pill is a path you want to take. Do not just line up to take it because someone on TV or Facebook says it is obvious you must.
And if anyone chooses not to take it, remember that is none of your business. If you still do not understand why it is none of your business, see below.
Further reading at the following links: